Effect of Toll-like receptor 7 agonist on JNK signaling pathway during liver injury in septic mice
10.3760/cma.j.issn.0254-1416.2016.05.028
- VernacularTitle:Toll样受体7激动剂对脓毒症小鼠肝损伤时JNK信号通路的影响
- Author:
Suqian GUO
;
Yu ZHANG
;
Qi ZHAO
;
Lan WU
;
Yonghao YU
;
Guolin WANG
- Publication Type:Journal Article
- Keywords:
Toll-like receptor 7;
Sepsis;
Proto-oncogene proteins c-jun;
Liver
- From:
Chinese Journal of Anesthesiology
2016;36(5):613-615
- CountryChina
- Language:Chinese
-
Abstract:
Objective To evaluate the effect of Toll-like receptor 7 (TLR7) agonist on c-Jun Nterminal kinase (JNK) signaling pathway during liver injury in the septic mice.Methods One hundred eighty pathogen-free adult male C57BL/6 mice,aged 10-14 weeks,weighing 20-26 g,were randomly divided into 3 groups (n=60 each) using a random number table:sham operation group (group S);sepsis group (group Sep);TLR7 agonist group (group GDQ).Sepsis was induced by cecum ligation and puncture.In group GDQ,TLR7 agonist 1.5 g/kg was injected intraperitoneally at 24 h before establishment of the model.At 6,12 and 24 h after operation,10 mice in each group were sacrificed,and the livers were removed to detect the expression of interleukin-6 (IL-6) and IL-10 by Western blot.The expression of JNK was determined by immuno-histochemistry,and the histopathologic changes of livers were examined with a light microscope at 24 h after operation.The survival of mice was observed at 14 days after operation,and the 14-day survival rates were calculated.Results Compared with group S,the 14-day survival rates were significantly decreased,and the expression of IL-6,IL-10 and JNK was significantly up-regulated at 6,12 and 24 h after operation in Sep and GDQ groups (P＜0.05).Compared with group Sep,the 14-day survival rates were significantly increased,and the expression of IL-6,IL-10 and JNK was significantly down-regulated at 6,12 and 24 h after operation in group GDQ (P＜0.05).The pathological changes of livers were significantly attenuated in group GDQ as compared with group Sep.Conclusion TLR7 agonist can reduce the liver injury through blocking the JNK signaling pathway in the septic mice.
